Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes

J Immunother Cancer · 2024 · PMC10916116

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In our robustly matched cohort of patients with mNSCLC+/−PNS, we showed that there was a trend towards worse OS among patients with PNS although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.